Hanlon Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $339K | Buy |
2,642
+253
| +11% | +$29.6K | 0.18% | 166 |
|
|
2026
Q1 | $287K | Buy |
2,389
+203
| +9% | +$23.4K | 0.16% | 179 |
|
|
2025
Q4 | $230K | Buy |
+2,186
| New | +$205K | 0.13% | 188 |
|
|
2025
Q1 | – | Sell |
-4,601
| Closed | -$458K | – | 188 |
|
|
2024
Q4 | $458K | Buy |
4,601
+540
| +13% | +$55.7K | 0.12% | 114 |
|
|
2024
Q3 | $461K | Buy |
4,061
+164
| +4% | +$19.5K | 0.13% | 113 |
|
|
2024
Q2 | $482K | Buy |
3,897
+438
| +13% | +$56.4K | 0.14% | 94 |
|
|
2024
Q1 | $456K | Buy |
3,459
+271
| +9% | +$33.4K | 0.14% | 94 |
|
|
2023
Q4 | $348K | Sell |
3,188
-256
| -7% | -$26.6K | 0.11% | 100 |
|
|
2023
Q3 | $355K | Buy |
3,444
+488
| +17% | +$52.6K | 0.11% | 108 |
|
|
2023
Q2 | $341K | Buy |
2,956
+400
| +16% | +$45.4K | 0.1% | 109 |
|
|
2023
Q1 | $272K | Buy |
2,556
+182
| +8% | +$19.6K | 0.08% | 112 |
|
|
2022
Q4 | $263K | Sell |
2,374
-47
| -2% | -$4.8K | 0.09% | 104 |
|
|
2022
Q3 | $208K | Hold |
2,421
| – | – | 0.08% | 99 |
|
|
2022
Q2 | $221K | Buy |
+2,421
| New | +$215K | 0.05% | 108 |
|
|
2021
Q3 | – | Sell |
-2,636
| Closed | -$205K | – | 138 |
|
|
2021
Q2 | $205K | Sell |
2,636
-123
| -4% | -$9.15K | 0.04% | 130 |
|
|
2021
Q1 | $203K | Buy |
2,759
+2
| +0.1% | +$148 | 0.04% | 126 |
|
|
2020
Q4 | $215K | Buy |
2,757
+2
| +0.1% | +$153 | 0.05% | 113 |
|
|
2020
Q3 | $218K | Buy |
2,755
+3
| +0.1% | +$235 | 0.07% | 100 |
|
|
2020
Q2 | $203K | Sell |
2,752
-3,433
| -56% | -$258K | 0.06% | 105 |
|
|
2020
Q1 | $454K | Buy |
6,185
+3,416
| +123% | +$268K | 0.29% | 53 |
|
|
2019
Q4 | $240K | Buy |
2,769
+24
| +0.9% | +$1.97K | 0.05% | 97 |
|
|
2019
Q3 | $220K | Sell |
2,745
-2,741
| -50% | -$220K | 0.06% | 79 |
|
|
2019
Q2 | $439K | Hold |
5,486
| – | – | 0.03% | 86 |
|
|
2019
Q1 | $435K | Buy |
+5,486
| New | +$410K | 0.05% | 78 |
|
|
2017
Q2 | – | Sell |
-44,695
| Closed | -$2.71M | – | 92 |
|
|
2017
Q1 | $2.71M | Buy |
+44,695
| New | +$2.71M | 0.34% | 48 |
|
|
2016
Q3 | – | Sell |
-92,333
| Closed | -$5.08M | – | 89 |
|
|
2016
Q2 | $5.08M | Buy |
+92,333
| New | +$4.91M | 0.44% | 33 |
|
|
2016
Q1 | – | Sell |
-78,770
| Closed | -$3.97M | – | 99 |
|
|
2015
Q4 | $3.97M | Buy |
+78,770
| New | +$3.97M | 0.38% | 34 |
|
Other funds holding MRK
Hanlon Investment Management's MRK Position: Q2 2026 in Review
Hanlon Investment Management increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $29.6K and bringing the position to 2,642 shares worth $339K. The position accounts for 0.18% of the portfolio, ranked #166.
Hanlon Investment Management first reported a position in MRK in Q4 2015 and has held it in 27 quarters since. The position peaked at $5.08M in Q2 2016. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Hanlon Investment Management held 2,642 shares of Merck worth $339K as of Q2 2026.
- Hanlon Investment Management bought 253 Merck shares in Q2 2026, an estimated $29.6K.
- Merck made up 0.18% of Hanlon Investment Management's portfolio in Q2 2026, its #166 holding.
- Hanlon Investment Management first reported a position in Merck in Q4 2015 and has held it in 27 quarters since.
- Hanlon Investment Management's Merck position peaked at $5.08M in Q2 2016.
- 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Hanlon Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.